Evidence map›Paper›PMID 39386203›Full record

ArticleFrontiers in immunology2024

Differential expression of HIV target cells CCR5 and α4β7 in tissue resident memory CD4 T cells in endocervix during the menstrual cycle of HIV seronegative women.

Sakthivel Govindaraj, Staple Tyree, Gina Bailey Herring, Sadia J Rahman, Hemalatha Babu, Chris Ibegbu, Marisa R Young, C Christina Mehta, Lisa B Haddad, Alicia K Smith and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sakthivel GovindarajDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.
Staple TyreeDepartment of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
Gina Bailey HerringDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Sadia J RahmanDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.
Hemalatha BabuDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.
Chris IbegbuDivision of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.
Marisa R YoungDepartment of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
C Christina MehtaDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Lisa B HaddadDepartment of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
Alicia K SmithDepartment of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
Vijayakumar VeluDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI WALLEN, KIM · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Combined cytokine therapy for sustained HIV remissionR01AI148377 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO, VELU, VIJAYAKUMAR · 2020 to 2024
$4.6M
Immunologic changes associated with three progestin-based contraceptives: characterizing immune profiles over one year and identifying factors that may alter HIV riskR01HD095741 · NICHD · EMORY UNIVERSITY · PI HADDAD, LISA BLAKE, SMITH, ALICIA K · 2018 to 2022
$3.8M
NCRR NIH HHS P51 RR000165NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI148377NICHD NIH HHS R01 HD095741
6 · The paper itself

Abstract

Background: Ovarian hormones are known to modulate the immune system in the female genital tract (FGT). We sought to define the impact of the menstrual cycle on the mucosal HIV target cell levels, and tissue-resident CD4 T cells. Materials and methods: Here, we characterized the distribution, phenotype, and function of CD4 T cells with special emphasis on HIV target cells (CCR5+ and α4β7+) as well as tissue-resident memory (TRM; CD69+ and CD103+) CD4 T cells in FGT of cycling women. Peripheral blood and Endocervical cells (EC-collected from cytobrush) were collected from 105 healthy women and performed multicolor flow cytometry to characterize the various subsets of CD4 T cells. Cervicovaginal lavage (CVL) were collected for cytokine analysis and plasma were collected for hormonal analysis. All parameters were compared between follicular and luteal phase of menstrual cycle. Results: Our findings revealed no significant difference in the blood CD4 T cell subsets between the follicular and luteal phase. However, in EC, the proportion of several cell types was higher in the follicular phase compared to the luteal phase of menstrual cycle, including CCR5+α4β7-cells (p=0.01), CD69+CD103+ TRM (p=0.02), CCR5+CD69+CD103+ TRM (p=0.001) and FoxP3+ CD4 T cells (p=0.0005). In contrast, α4β7+ CCR5- cells were higher in the luteal phase (p=0.0004) compared to the follicular phase. In addition, we also found that hormonal levels (P4/E2 ratio) and cytokines (IL-5 and IL-6) were correlated with CCR5+ CD4 T cells subsets during the follicular phase of the menstrual cycle. Conclusion: Overall, these findings suggest the difference in the expression of CCR5 and α4β7 in TRM CD4 T cell subsets in endocervix of HIV seronegative women between the follicular and luteal phase. Increase in the CCR5+ expression on TRM subsets could increase susceptibility to HIV infection during follicular phase of the menstrual cycle.

Indexed as

CD4-Positive T-LymphocytesCervix UteriImmunologic MemoryMenstrual CycleReceptors, CCR5AdultCytokinesFemaleHIV InfectionsHumansIntegrinsT-Lymphocyte SubsetsYoung AdultCCR5 protein, humanCytokinesintegrin alpha4beta7IntegrinsReceptors, CCR5endocervixHIV susceptibilityHIV target cellsmenstrual cycle phaseTRM

Identifiers

PMID39386203
PMCPMC11461385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.